article thumbnail

‘The most meaningful cannabis reform in decades’: Experts weigh in on new DEA rules

The Cannigma

The federally sanctioned cannabis did not reflect the products available in dispensaries around the country, researchers complain, limiting the scope of research and pushing much of it overseas. The BRC is among the dozens of organizations that have received preliminary approval from the DEA to cultivate cannabis. Shutterstock).

DEA 133
article thumbnail

U.S. Cannabis Legalization Update: Who’s Still Waiting and Who May Legalize

Veriheal

states and the District of Columbia currently have legal cannabis, medical or recreational. Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. To its credit, the state does seem to be making minor strides toward cannabis legalization lately.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NIDA Monopoly is Over: New DEA-Registered Cannabis Growers Can Supply Researchers with Product

Cannabis Law Report

It seems like every day I read a new story about legislators, high-ranking federal officials, and frustrated advocates of marijuana research complaining that researchers still can’t study the actual marijuana that people are using in the state-legal markets. Drug Enforcement Agency (DEA) to cultivate marijuana for research purposes.

DEA 52
article thumbnail

The DEA Is Finally About to End the Federal Monopoly on Research Cannabis Cultivators

SpeedWeed

After years of delays, legal challenges, and obfuscation, the US Drug Enforcement Agency (DEA) finally announced that it would begin evaluating applications for federally-licensed research cannabis cultivators. . In 2019, a federal judge forced the DEA to explain its inaction.

DEA 52
article thumbnail

The Week in Weed: January 5, 2024

The Blunt Truth

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. The DEA is conducting a review of cannabis scheduling. As of January 2024, 24 states have legalized adult-use cannabis; over half the US population lives in a state where it is legal. million in taxes and fees.

DEA 52
article thumbnail

Study Finds Research-Grade Cannabis Differs From Commercial Cannabis

Veriheal

According to a new study published in September, the cannabis grown by the federal government for research purposes doesn’t accurately reflect what consumers are buying in dispensaries across the United States. The findings have raised serious questions about the efficacy of federal cannabis research. or less THC. .” ” U.S.

DEA 104
article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

Though it doesn’t get users high like THC-dominant products, CBD is all the rage these days due to its medical benefits and gray-area legality. On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances.

DEA 51